Related Experiment Video
Updated: Nov 19, 2025
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Cord Blood-Based Approach to Assess Candidate Vaccine Adjuvants Designed for Neonates and Infants
Daisuke Tokuhara1, Norikatsu Hikita1
1Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Insights
Infants have weaker vaccine immunity due to immature innate immune responses, particularly toll-like receptors. Understanding infant immunity is crucial for developing effective pediatric vaccines and adjuvants.
Area of Science:
- Immunology
- Pediatrics
- Vaccinology
Background:
- Neonates and infants are highly vulnerable to severe infections.
- Vaccine-induced immunity is often less effective in infants compared to adults.
- Immature innate immunity, including toll-like receptors, may explain reduced vaccine responses in infants.
Purpose of the Study:
- To review current knowledge of infant innate immunity.
- To identify challenges in developing pediatric vaccines and adjuvants.
- To analyze cord blood for insights into neonatal immune responses.
Main Methods:
- Literature review of infant innate immunity.
- Analysis of cord blood immune markers.
- Examination of existing pediatric vaccine development strategies.
Main Results:
- Infant innate immune responses, including toll-like receptor function, are underdeveloped.
- Current vaccine development often overlooks the unique immunological profile of infants.
- Cord blood analysis provides a window into neonatal immune immaturity.
Conclusions:
- Developing effective vaccines for infants requires a deep understanding of their immature innate immune system.
- Novel vaccine adjuvants tailored to infant immunity are needed.
- Future pediatric vaccine strategies must account for age-specific immune development.
Abstract:
Neonates and infants are particularly susceptible to infections, for which outcomes tend to be severe. Vaccination is a key strategy for preventing infectious diseases, but the protective immunity achieved through vaccination typically is weaker in infants than in healthy adults. One possible explanation for the poor acquisition of vaccine-induced immunity in infants is that their innate immune response, represented by toll-like receptors, is immature. The current system for developing pediatric vaccines relies on the confirmation of their safety and effectiveness in studies involving the use of mature animals or adult humans. However, creating vaccines for neonates and infants requires an understanding of their uniquely immature innate immunity. Here we review current knowledge regarding the innate immune system of neonates and infants and challenges in developing vaccine adjuvants for those children through analyses of cord blood.
More Related Videos
Related Concept Videos
01:29Drug Dosing: Infants and Children
01:19Rh Blood Group